RxDoctor Payments Data

Jena King

Nurse Practitioner · Portage, MINPI 1467647214

Payments from drug & device makers

$890in general payments, 2019–2025

Across 42 payments — averaging $21.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$230
  • AbbVie$98
  • Astellas Pharma US Inc$60
  • Pfizer$58
  • Abbott$47
  • Lilly USA, LLC$47
  • plus $350 from 15 others

What the payments were for

  • Food & beverage$890100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$890 in reported general payments places this provider in the 80th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Medicare billing

Part B allowed, 2024
$18,058
Medicare patients
86
Services billed
234

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin44$50,025
OzempicSemaglutide12$32,260
EliquisApixaban17$20,467
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$13,807
Bydureon BciseExenatide Microspheres11$8,757
Atorvastatin Calcium226$4,800
Levothyroxine Sodium218$3,033
Duloxetine Hcl47$2,325
Lisinopril167$1,864
Rosuvastatin Calcium104$1,854
Omeprazole87$1,841
Metoprolol Succinate94$1,669
Metformin Hcl ErMetformin Hcl113$1,666
Pantoprazole Sodium59$1,319
Sertraline Hcl85$1,296

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$21$50,02544 claims
Novo NordiskOzempic$230$32,26012 claims
PfizerEliquis$58$20,46717 claims
GSKTrelegy Ellipta$30$13,80714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Portage

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →